MARİA ALEXANDRA MONTENEGRO, TİAGO DİAS DOMİNGUES, TERESA MOTA GARCİA, RİTA QUARESMA FERREİRA, IVÁNİA TAVARES FURTADO, RUİ ESCALEİRA, FİLİPA R VERDASCA, DİANA CARDOSO SİMÃO, LEONOR FERNANDES, SÓNİA DUARTE OLİVEİRA
European Journal of Breast Health - 2025;21(2):154-161
Objective: Male breast cancer (MBC) is a rare malignancy, representing less than 1% of all breast cancer cases. Despite the rising incidence, MBC research remains limited, with most data extrapolated from female breast cancer (FBC). This study evaluated the clinicopathological features, treatment strategies, and survival outcomes of MBC patients in Portugal over two decades.
